MicroRNA Expression Profiling in Adrenal Myelolipoma

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3522-3530. doi: 10.1210/jc.2018-00817.


Introduction: Adrenal myelolipoma (AML) is the second most common and invariably benign primary adrenal neoplasm. Due to the variable proportion of fat and hematopoietic elements and its often large size, it can cause differential diagnostic problems. Several reports confirmed the utility of miRNAs in the diagnosis of tumors, but miRNA expression in AML has not yet been investigated.

Materials and methods: Next-generation sequencing (NGS) was performed on 30 formalin-fixed, paraffin-embedded (FFPE) archived tissue samples [10 each of AML, adrenocortical adenoma (ACA), and adrenocortical carcinoma (ACC)]. Validation was performed by real-time quantitative reverse transcription polymerase chain reaction on a cohort containing 41 further FFPE samples (15 AML, 14 ACA, and 12 ACC samples). Circulating miRNA counterparts of significantly differentially expressed tissue miRNAs were studied in 33 plasma samples (11 each of ACA, ACC, and AML).

Results: By NGS, 256 significantly differentially expressed miRNAs were discovered, and 8 of these were chosen for validation. Significant overexpression of hsa-miR-451a, hsa-miR-486-5p, hsa-miR-363-3p, and hsa-miR-150-5p was confirmed in AML relative to ACA and ACC. hsa-miR-184, hsa-miR-483-5p, and hsa-miR-183-5p were significantly overexpressed in ACC relative to ACA but not to AML. Circulating hsa-miR-451a and hsa-miR-363-3p were significantly overexpressed in AML, whereas circulating hsa-miR-483-5p and hsa-miR-483-3p were only significantly overexpressed in ACC vs ACA.

Conclusions: We have found significantly differentially expressed miRNAs in AML and adrenocortical tumors. Circulating hsa-miR-451a might be a promising minimally invasive biomarker of AML. The lack of significantly different expression of hsa-miR-483-3p and hsa-miR-483-5p between AML and ACC might limit their applicability as diagnostic miRNA markers for ACC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Gland Neoplasms / blood
  • Adrenal Gland Neoplasms / genetics*
  • Adrenal Gland Neoplasms / pathology
  • Adrenocortical Adenoma / blood
  • Adrenocortical Adenoma / genetics
  • Adrenocortical Adenoma / pathology
  • Adrenocortical Carcinoma / blood
  • Adrenocortical Carcinoma / genetics
  • Adrenocortical Carcinoma / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism
  • Cohort Studies
  • Female
  • Gene Expression Profiling
  • Humans
  • Male
  • MicroRNAs / metabolism*
  • Middle Aged
  • Myelolipoma / blood
  • Myelolipoma / genetics*
  • Myelolipoma / pathology
  • Real-Time Polymerase Chain Reaction
  • Young Adult


  • Biomarkers, Tumor
  • MIRN150 microRNA, human
  • MIRN363 microRNA, human
  • MIRN451 microRNA, human
  • MIRN486 microRNA, human
  • MicroRNAs